Evotec SE (EVO)
NASDAQ: EVO · Real-Time Price · USD
4.160
-0.050 (-1.19%)
Apr 25, 2025, 4:00 PM EDT - Market closed
Evotec SE Employees
Evotec SE had 4,740 employees as of December 31, 2024. The number of employees decreased by 321 or -6.34% compared to the previous year.
Employees
4,740
Change (1Y)
-321
Growth (1Y)
-6.34%
Revenue / Employee
$174,072
Profits / Employee
-$42,827
Market Cap
1.49B
Employees Chart
Employees History
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
AbbVie | 55,000 |
EVO News
- 3 days ago - Evotec Announces Significant Progress in Strategic Protein Degradation Collaboration with Bristol Myers Squibb - Accesswire
- 10 days ago - Evotec SE (EVO) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 10 days ago - Evotec SE Unveils New Strategy and Provides 2025 Guidance Bolstered by Strong Q4 2024 Results - Accesswire
- 17 days ago - Evotec SE to Announce Results for Financial Year 2024 on 17 April 2025 - Accesswire
- 7 weeks ago - Evotec Announces Key Progress in Neuroscience Collaboration with Bristol Myers Squibb - Accesswire
- 2 months ago - Evotec Announces Change in Management Board - Accesswire
- 2 months ago - Advancing Data Centric AI in Healthcare and Life Sciences - Elucidata Onboards Former CEO of Evotec and Ex-McKinsey Senior Partner - Business Wire
- 3 months ago - Evotec Receives Grant from Korean Government to Develop Novel Antibody-based Treatments for Lung Diseases - Accesswire